# A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

> **NCT03193541** · — · RECRUITING · sponsor: **Cedars-Sinai Medical Center** · enrollment: 900 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03193541
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-12-30
- **Primary completion:** 2029-02
- **Final completion:** 2029-02
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2026-02-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03193541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03193541, "A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03193541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*